10-Q: Mativ Holdings Reports Mixed Q3 Results Amidst Restructuring Efforts
Quarterly Report
Mativ Holdings reported a net loss for the third quarter, despite a slight increase in net sales and ongoing restructuring efforts.
Summary
- Mativ Holdings reported net sales of $498.5 million for the third quarter of 2024, a marginal increase from $498.2 million in the same period last year.
- The company experienced a net loss of $20.8 million, or $0.38 per diluted share, compared to a net loss of $464.3 million, or $8.50 per diluted share, in the third quarter of 2023.
- Gross profit for the quarter was $93.6 million, up from $86.7 million year-over-year, driven by lower manufacturing costs.
- Nonmanufacturing expenses decreased to $75.4 million from $89.3 million in the prior year, primarily due to reduced expenses related to the EP Divestiture and integration.
- Restructuring and other impairment expenses totaled $11.2 million, down from $16.3 million in the same quarter last year.
- Operating profit was $7.0 million, a significant improvement from an operating loss of $419.9 million in the third quarter of 2023, which was impacted by a $401 million goodwill impairment.
- Interest expense increased to $18.3 million from $16.8 million year-over-year due to higher average balances and interest rates on debt.
- For the nine months ended September 30, 2024, net sales were $1,522.5 million, down from $1,573.7 million in the same period last year.
- The net loss for the nine-month period was $50.2 million, or $0.93 per diluted share, compared to a net loss of $494.1 million, or $9.06 per diluted share, in the prior year period.
- Cash provided by operating activities was $70.7 million for the nine months ended September 30, 2024, compared to $37.8 million in the prior year period.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to improved profitability metrics and cost management, but the company still faces challenges with net losses and debt. The successful capital raise and debt refinancing are positive developments.
Positives
- Gross profit increased due to lower manufacturing costs.
- Nonmanufacturing expenses decreased due to reduced expenses related to the EP Divestiture and integration.
- Operating profit improved significantly compared to the prior year period, which was impacted by a large goodwill impairment.
- Cash provided by operating activities increased year-over-year.
- The company's net leverage is within the maximum covenant ratio.
Negatives
- The company reported a net loss for the quarter.
- Net sales in the FAM segment decreased by 3.2% compared to the prior year quarter.
- Interest expense increased due to higher average balances and interest rates on debt.
- Net sales for the nine months ended September 30, 2024 decreased by 3.3% compared to the prior year period.
- The company incurred restructuring and other impairment expenses of $11.2 million in Q3 2024.
Risks
- The company is exposed to foreign currency exchange rate risk and interest rate risk on its variable-rate debt.
- The company's operations are subject to various environmental laws and regulations, which could lead to material costs or liabilities.
- Approximately 26% of the company's U.S. workforce and 34% of its Non-U.S. workforce are under collective bargaining agreements, some of which will expire in the next 12 months.
- The company's future performance is subject to various market and economic conditions, including changes in competition, customer demand, and supply chain disruptions.
Future Outlook
The company believes its sources of liquidity and capital will be sufficient to finance its continued operations, growth plan, and dividend payments. The company expects to remain in compliance with financial covenants under the Amended Credit Agreement.
Management Comments
- The company is monitoring and continues to adjust staffing levels of manufacturing labor relative to volumes.
- The company will continue to assess its dividend policy in light of its overall strategy, cash generation, debt levels and ongoing requirements for cash to fund operations and to pursue possible strategic opportunities.
Industry Context
The company operates in the specialty materials industry, targeting premium applications across diversified and growing end-markets. The results reflect the challenges of managing costs and demand in a complex global environment, while also executing on strategic initiatives such as restructuring and divestitures.
Comparison to Industry Standards
- The company's performance is mixed compared to industry benchmarks. While gross profit and operating profit showed improvement, the company still reported a net loss.
- The decrease in nonmanufacturing expenses is a positive sign, indicating progress in cost management.
- The company's debt levels and interest expenses remain a concern, which is common in the current economic environment.
- The company's restructuring efforts are aimed at improving efficiency and profitability, which is a common strategy in the industry.
- The company's performance in the FAM segment was weaker than in the SAS segment, indicating potential areas for improvement.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Anderson Warlick | NA | 2024-12-31 | Resignation |
Stakeholder Impact
- Shareholders will be impacted by the net loss, but also by the improved operating profit and the dividend payment.
- Employees may be impacted by the ongoing restructuring efforts and changes in staffing levels.
- Customers may benefit from the company's focus on improving efficiency and profitability.
- Creditors will be impacted by the company's debt levels and refinancing activities.
Next Steps
- The company will continue to execute its organizational realignment plan.
- The company will continue to monitor and adjust staffing levels of manufacturing labor relative to volumes.
- The company will continue to assess its dividend policy.
- The company will focus on improving performance in the FAM segment.
Key Dates
| Date | Description |
|---|---|
| 2018-09-25 | The company entered into a $700 million credit agreement and closed a private offering of $350 million of 6.875% senior unsecured notes due 2026. |
| 2021-02-10 | The company amended its credit agreement to add a new $350 million Term Loan B Facility. |
| 2022-05-06 | The company further amended its credit agreement to extend the maturity of the Revolving Credit Facility and the Term Loan A Facility and added a $650 million delayed draw term loan facility. |
| 2022-07-06 | Schweitzer-Mauduit International, Inc. completed a merger transaction involving Neenah, Inc. and changed its name to Mativ Holdings, Inc. |
| 2022-12-23 | The company entered into an accounts receivables sales agreement. |
| 2023-10-20 | The company entered into Amendment No. 1 to the Receivables Sales Agreement. |
| 2023-11-30 | The company completed the sale of the Engineered Papers business. |
| 2024-01-01 | The company reorganized into two new reportable segments: Filtration & Advanced Materials (FAM) and Sustainable & Adhesive Solutions (SAS). |
| 2024-09-24 | The company priced its private offering of $400,000,000 in aggregate principal amount of its 8.000% senior notes due 2029. |
| 2024-09-30 | End of the reporting period for the third quarter. |
| 2024-10-07 | The company closed its private offering of $400,000,000 of its 8.000% Senior Notes due 2029 and redeemed its 6.875% Senior Notes due 2026. |
| 2024-11-01 | The company completed the sale of Neenah Global Holdings B.V. and its subsidiaries in Eerbeek, Netherlands. |
| 2024-11-05 | Anderson Warlick provided the Board of Directors notice of his resignation from the Board, effective December 31, 2024. |
| 2024-11-06 | The company announced a cash dividend of $0.10 per share payable on December 20, 2024. |
| 2024-11-29 | Record date for the cash dividend of $0.10 per share. |
| 2024-12-20 | Payment date for the cash dividend of $0.10 per share. |
| 2024-12-31 | Effective date of Anderson Warlick's resignation from the Board of Directors. |
Keywords
restructuring, financial results, net sales, operating profit, net loss, debt, segment performance, impairment, cash flow, manufacturing costs
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.